MedPath

GLENMARK PHARMACEUTICALS INC., USA

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

164

FDA:164

Drug Approvals

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate

Approval Date
May 10, 2025
FDA

Topiramate

Approval Date
May 7, 2025
FDA

Acetylcysteine

Approval Date
Mar 25, 2025
FDA

Fluconazole

Approval Date
Mar 28, 2024
FDA

ezetimibe and simvastatin

Approval Date
Mar 18, 2024
FDA

ESTRADIOL VAGINAL INSERTS

Approval Date
Mar 11, 2024
FDA

Telmisartan

Approval Date
Mar 7, 2024
FDA

Clindamycin Phosphate

Approval Date
Jan 23, 2024
FDA

Bisoprolol Fumarate and Hydrochlorothiazide

Approval Date
Jan 18, 2024
FDA

DIMETHYL FUMARATE

Approval Date
Jan 12, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.